Efficacy and Safety of Almonertinib Combined With or Without Chemotherapy as an Adjuvant Treatment for Stage II-IIIA Non-small Cell Lung Carcinoma Following Complete Tumour Resection
Clinical trial NCT04762459 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT04762459
- Sponsor
- Chinese Academy of Medical Sciences
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-01
- Primary completion
- 2026-05-01
- Enrollment
- 606
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.